Concepedia

Rose Sheridan

RS

Statistics

Publications

27

Citations

1.4K

H-Index

21

Active since

2000

Affiliations

University of Cambridge(Current)

University College London

Universidad de Oviedo

Pfizer (United States)

University of Chester

Rose Sheridan is an author at University of Cambridge specializing in polyketide biosynthesis, life sciences, and natural product biosynthesis.

Publications per year

2000–2025

27

Publications

27

Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial

Rhian Raftopoulos, Simon J. Hickman, Ahmed Toosy et al. · The Lancet Neurology · 2016 · 195 citations · Full text

, , +11

Biosynthesis of the Angiogenesis Inhibitor Borrelidin by Streptomyces parvulus Tü4055

Carlos Olano, Barrie Wilkinson, César Sánchez et al. · Chemistry & Biology · 2004 · 151 citations · Full text

, , +10

Roles of <i>rapH</i> and <i>rapG</i> in Positive Regulation of Rapamycin Biosynthesis in <i>Streptomyces hygroscopicus</i>

Enej Kuščer, Nigel Coates, Iain R. Challis et al. · Journal of Bacteriology · 2007 · 114 citations

, , +16

Mutasynthesis of Rapamycin Analogues through the Manipulation of a Gene Governing Starter Unit Biosynthesis

Matthew A. Gregory, Hrvoje Petković, Rachel E. Lill et al. · Angewandte Chemie International Edition · 2005 · 107 citations

, , +5

Optimizing Natural Products by Biosynthetic Engineering: Discovery of Nonquinone Hsp90 Inhibitors

Ming‐Qiang Zhang, Sabine Gaisser, Mohammad Nur‐e‐Alam et al. · Journal of Medicinal Chemistry · 2008 · 86 citations · Full text

, , +17

1–5 of 27